Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06722807 · ClinicalTrials.gov registry record · NA
ClAmpless, Sutureless PartIAl Nephrectomy for Renal Masses
A NA study of Renal Cell Carcinoma (RCC), sponsored by University of Florida.
- Recruiting
- Registry status
- NA
- Development phase
- 59
- Enrollment target
- 1
- Study location
NCT06722807: Recruiting NA study of Renal Cell Carcinoma (RCC), sponsored by University of Florida.
NCT06722807 is a NA study of Renal Cell Carcinoma (RCC) that is actively recruiting participants, run by University of Florida. The registered enrollment target is 59 participants, below the 406-participant average among 12 other Renal Cell Carcinoma (RCC) trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06722807, a NA study of Renal Cell Carcinoma (RCC), is actively recruiting participants, sponsored by University of Florida.
- RECRUITING
- Registry status
- NA
- Development phase
- 59 participants
- Enrollment target
- 1
- Study location
Study Summary
During partial nephrectomy surgery, efforts at minimizing ischemia while maximizing renal parenchymal volume are desirable to preserve renal function1,2. Not only clamping of the hilum but the renorrhaphy portion of the procedure also can have a significant negative impact on renal function3-5. It is possible to perform this procedure without clamping the hilum and also without formal renorrhaphy. However robust prospective formal evaluation of safety, risks, and potential benefits and whether or not the technique can be employed in a generalized fashion has not been studied. Demonstration of safety and generalizability may open a whole new avenue of approaching nephron sparing and renal function sparing kidney surgery and decrease potential risks for long term kidney disease in patients with renal masses. This study will investigate the safety, efficacy, and generalizability of the use of clampless, sutureless partial nephrectomy in the treatment of renal cell carcinoma.
Conditions Studied
Interventions
- PROCEDURE sutureless, clampless partial nephrectomy
Study Locations (1)
Florida
- University of Florida - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2025-06-10 |
| Est. Completion | 2027-01 |
| Phase | NA |
What NCT06722807 shows while recruiting
NCT06722807 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 59 participants, a relatively small participant target, below the 406-participant average among 12 other Renal Cell Carcinoma (RCC) trials with a reported enrollment target (85% lower).
The record links to 1 condition, with Renal Cell Carcinoma (RCC) appearing as the primary indexed condition, and to 1 intervention - of which sutureless, clampless partial nephrectomy is the first listed.
NCT06722807 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT06722807 about?
NCT06722807 is a clinical study titled "ClAmpless, Sutureless PartIAl Nephrectomy for Renal Masses". During partial nephrectomy surgery, efforts at minimizing ischemia while maximizing renal parenchymal volume are desirable to preserve renal function1,2. Not only clamping of the hilum but the renorrhaphy portion of the procedure also can have a significant negative impact on renal function3-5. It i...
What is the current status of trial NCT06722807?
This trial is currently recruiting. It is a NA study. The enrollment target is 59 participants. The study started on 2025-06-10. Estimated completion is 2027-01.
What conditions does trial NCT06722807 study?
This clinical trial studies the following conditions: Renal Cell Carcinoma (RCC).
What interventions are being tested in trial NCT06722807?
The interventions under investigation include: sutureless, clampless partial nephrectomy (PROCEDURE).
Who is sponsoring clinical trial NCT06722807?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06722807 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Renal Cell Carcinoma (RCC)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06722807's enrollment target sits among peer trials
59 10th of 12 higher than 3 of 12 other Renal Cell Carcinoma (RCC) trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Renal Cell Carcinoma (RCC) trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
"Embolization Before Ablation of Renal Cell Carcinoma (EMBARC)"
RECRUITING · NA
-
Investigation of Lymph Node Biology in Kidney Cancer
RECRUITING · NA
-
Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors
RECRUITING · Phase 1
-
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
RECRUITING · Phase 1
-
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
RECRUITING · Phase 3
-
Study to Evaluate LB-LR1109, Administered Alone for the Treatment of Solid Tumor and in Combination With Atezolizumab for the Treatment of NSCLC
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03801083 · 59 participants · Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers
- NCT04332367 · 59 participants · Phase 2
Carboplatin, Taxane And Ramucirumab for Patients With NSCLC After Pemetrexed or Pembrolizumab Maintenance
- NCT05489575 · 59 participants · NA
CPAP for the Treatment of Supine Hypertension
- NCT06721689 · 59 participants · Phase 1
PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI